Microcompetition explains the underlying cause of many major diseases and shows how latent viruses actually can cause disease while still latent.
According to the FDA, active viruses cause disease; latent viruses do not. The Center for the Biology of Chronic Disease (CBCD), in contrast, supports an alternative view. Microcompetition explains the underlying cause of many major diseases and shows how latent viruses actually can cause disease while still latent.
Why is this important? It is important because HPV has the ability to establish a latent infection. Most people who have an HPV infection do not know they are infected because many types of the virus remain latent and cause no symptoms.
The FDA says people shouldn’t be worried about a latent infection. The CBCD says otherwise.
A recent study entitled “Prevelance of Oral HPV Infection in the United States, 2009 – 2010” that was published in the Journal of the American Medical Association (JAMA) reported that the HPV virus was found in the mouths of 7% of study participants. 5,600 people participated in the study. Oral HPV was found in men more than in women. 
The authors of the study wrote, “The prevalence of oral HPV infection among men and women aged 14 to 69 years in the United States is approximately 7%… Infection with HPV-16, (a specific type of HPV most associated with cancer) was detected in 1% of men and women, corresponding to an estimated 2.13 million infected individuals in the United States.”
HPV has the ability to establish a latent infection. Chronic infections can lead to cancer.
In essence, according to the study, 2.13 million people who don’t have symptoms now, and don’t even know they are infected, could develop cancer due to their HPV infection.
In contrast to the FDA’s claims, the CBCD believes this is true regardless of whether the virus is active or latent.
According to Dr. Hanan Polansky, the latent HPV virus microcompetes with human genes for scarce genetic resources, and as a result, can drive the human genes to malfunction, which eventually causes illnesses. In fact, according to Dr. Hanan Polansky’s highly acclaimed “Purple Book,” entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease,” latent viruses, in high concentration, are the cause of many major diseases, such as cancer, heart disease, diabetes, arthritis, and many more.
The CBCD encourages biologists, virologists, physicians and those at the FDA and CDC to download and read Dr. Polansky’s book in depth.
Some scientists believe that if a virus is latent, then microcompetition is irrelevant. This belief is simply wrong. A latent virus is not dead. It continues to express some of its proteins and therefore microcompetes with human genes.
Consider the paper entitled “Human Cytomegalovirus Persistence” published February 13, 2012 in the journal Cellular Microbiology. 
“Both the chronic and latent states of infection contribute to HCMV persistence and to the high HCMV seroprevalence worldwide. The chronic infection is poorly defined molecularly, but clinically manifests as low-level virus shedding over extended periods of time and often in the absence of symptoms.”
A virus is still shedding copies of itself during the latent state.
The same paper goes on to say: “Transcripts and proteins encoded from a region encompassing the major immediate early region are detected in hematopoietic cells following infection in vitro as well as in latently infected individuals.” (Kondo et al., 1996; Landini et al., 2000).
As mentioned above, the virus continues to express some of its proteins during latency.
While the paper above is discussing the Cytomegalovirus, the principles are the same for other viruses such as HPV.
What does it all mean? Latent viruses can cause disease even without activating, or while still latent. This means that people must fight the latent viruses in their bodies.
So how can one fight the latent HPV virus?
It’s not easy. The two possible ways to attack the sleeping HPV virus is through vaccines and antiviral medications. The vaccine, according to its makers, only protects against 4 strains of HPV. Since there are well over 100 strains of HPV, one can see how limited the HPV vaccine’s protection really is. The vaccine is also associated with a controversial safety record:
For a more detailed discussion of the above, please go here:
“The key to your health is to reduce the level of chronic viruses in your body to harmless levels.” – Dr. Hanan Polansky
The CBCD encourages people to combat the latent HPV.
For more information on the Center for the Biology of Chronic Disease, or to schedule an interview with one of our researchers, please visit http://www.cbcd.net or call 585-250-9999.